RSCM
IMCR icon

Rock Springs Capital Management’s Immunocore IMCR Stock Holding History

Rock Springs Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-419,030
Closed -$14.2M – 115
2024
Q2 		$14.2M Sell
419,030
-1,948,786
-82% -$99.4M 0.43% 59
2024
Q1 		$154M Sell
2,367,816
-293,691
-11% -$20.2M 3.91% 2
2023
Q4 		$182M Sell
2,661,507
-282,203
-10% -$14.7M 4.48% 2
2023
Q3 		$153M Sell
2,943,710
-84,700
-3% -$5.01M 4.09% 2
2023
Q2 		$182M Buy
3,028,410
+26,748
+0.9% +$1.53M 4.32% 2
2023
Q1 		$148M Sell
3,001,662
-319,404
-10% -$18M 3.54% 4
2022
Q4 		$190M Sell
3,321,066
-172,677
-5% -$9.72M 4.56% 2
2022
Q3 		$164M Buy
3,493,743
+822,091
+31% +$39.2M 4.24% 3
2022
Q2 		$99.7M Buy
2,671,652
+119,618
+5% +$3.89M 2.9% 7
2022
Q1 		$76.3M Buy
2,552,034
+80,479
+3% +$2.03M 1.92% 15
2021
Q4 		$84.6M Buy
2,471,555
+26,400
+1% +$956K 1.96% 13
2021
Q3 		$90.6M Buy
2,445,155
+50,370
+2% +$1.7M 1.91% 14
2021
Q2 		$93.5M Buy
2,394,785
+102,500
+4% +$3.96M 1.85% 13
2021
Q1 		$97.6M Buy
+2,292,285
New +$102M 2.13% 8

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Rock Springs Capital Management's IMCR Position: Q3 2024 in Review

Rock Springs Capital Management sold out of Immunocore (IMCR) in Q3 2024, closing a stake of 419,030 shares — an estimated $14.2M sold.

Rock Springs Capital Management first reported a position in IMCR in Q1 2021 and held it in 14 quarters. The position peaked at $190M in Q4 2022. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2024.

  • Rock Springs Capital Management reported no remaining Immunocore position as of Q3 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 419,030 Immunocore shares in Q3 2024, an estimated $14.2M.
  • Rock Springs Capital Management first reported a position in Immunocore in Q1 2021 and held it in 14 quarters.
  • Rock Springs Capital Management's Immunocore position peaked at $190M in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2024.

Based on Rock Springs Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.